³í¹®) Evaluation of the Prognosis of COVID-19 Patients According to the Presence of Underlying Diseases and Drug Treatment
¼¿ï´ëÇб³º´¿ø¿î¿µ ¼¿ïƯº°½Ãº¸¶ó¸Åº´¿ø(¿øÀå Á¤½Â¿ë) ½ÅÀå³»°ú ÀÌÁ¤Ç¥ ±³¼ö(»çÁø ñ§)¿Í ¼¿ï´ëÇб³ º¸°Ç´ëÇпø(¿øÀå À̱⿵) ±è È£ ±³¼ö(éÓ) ¿¬±¸ÆÀ